analiza aiqbench
Xanadu and the University of Alberta are collaborating to use quantum algorithms for simulating photosensitizers in photodynamic therapy, aiming to overcome classical computing limitations in modeling light-matter interactions for cancer treatment. This partnership leverages early fault-tolerant quantum hardware to accelerate drug discovery workflows specifically designed around complex molecular simulations rather than general-purpose AI tasks.
Xanadu and Alberta U. seek better cancer drugs with quantum chips

Xanadu Quantum Technologies & the University of Alberta are partnering to seek better cancer drugs, developing quantum algorithms for photosensitizers used in photodynamic therapy.
Xanadu (NASDAQ/TSX: XNDU) is investing in pharmaceutical research through a new partnership with the University of Alberta to accelerate the design of compounds for photodynamic therapy, a cancer treatment that avoids chemotherapy side effects. The collaboration unites Xanadu’s quantum computing framework with the published…
Extras afișat conform termenilor RSS ai publicației · 44 cuvinte · textul integral și figurile sunt pe site-ul publicației


